{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T22:59:25Z","timestamp":1790290765679,"version":"4.1.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T00:00:00Z","timestamp":1749513600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T00:00:00Z","timestamp":1749513600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Microbiol"],"DOI":"10.1038\/s41564-025-02033-4","type":"journal-article","created":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T09:03:40Z","timestamp":1749546220000},"page":"1711-1722","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Breadth of influenza A antibody cross-reactivity varies by virus isolation interval and subtype"],"prefix":"10.1038","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0811-8332","authenticated-orcid":false,"given":"Bingyi","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katelyn M.","family":"Gostic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dillon C.","family":"Adam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ru","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tal","family":"Einav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liping","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1290-191X","authenticated-orcid":false,"given":"Sook San","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim K.","family":"Tsang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek A. T.","family":"Cummings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0856-0294","authenticated-orcid":false,"given":"Sheena G.","family":"Sullivan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5298-8979","authenticated-orcid":false,"given":"Sarah","family":"Cobey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6297-7154","authenticated-orcid":false,"given":"Benjamin J.","family":"Cowling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,10]]},"reference":[{"key":"2033_CR1","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1016\/S0140-6736(17)33293-2","volume":"391","author":"AD Iuliano","year":"2018","unstructured":"Iuliano, A. D. et al. Estimates of global seasonal influenza-associated respiratory mortality: a modelling study. Lancet 391, 1285\u20131300 (2018).","journal-title":"Lancet"},{"key":"2033_CR2","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.81457","volume":"11","author":"B Yang","year":"2022","unstructured":"Yang, B. et al. Long term intrinsic cycling in human life course antibody responses to influenza A(H3N2): an observational and modeling study. Elife 11, e81457 (2022).","journal-title":"Elife"},{"key":"2033_CR3","doi-asserted-by":"publisher","first-page":"e1008635","DOI":"10.1371\/journal.ppat.1008635","volume":"16","author":"B Yang","year":"2020","unstructured":"Yang, B. et al. Life course exposures continually shape antibody profiles and risk of seroconversion to influenza. PLoS Pathog. 16, e1008635 (2020).","journal-title":"PLoS Pathog."},{"key":"2033_CR4","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1016\/j.tim.2021.05.009","volume":"29","author":"RJ Oidtman","year":"2021","unstructured":"Oidtman, R. J. et al. Influenza immune escape under heterogeneous host immune histories. Trends Microbiol. 29, 1072\u20131082 (2021).","journal-title":"Trends Microbiol."},{"key":"2033_CR5","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1126\/science.1256427","volume":"346","author":"JM Fonville","year":"2014","unstructured":"Fonville, J. M. et al. Antibody landscapes after influenza virus infection or vaccination. Science 346, 996\u20131000 (2014).","journal-title":"Science"},{"key":"2033_CR6","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/s41577-019-0143-6","volume":"19","author":"F Krammer","year":"2019","unstructured":"Krammer, F. The human antibody response to influenza A virus infection and vaccination. Nat. Rev. Immunol. 19, 383\u2013397 (2019).","journal-title":"Nat. Rev. Immunol."},{"key":"2033_CR7","doi-asserted-by":"publisher","first-page":"2000","DOI":"10.1056\/NEJMc0907256","volume":"361","author":"DN Fisman","year":"2009","unstructured":"Fisman, D. N. et al. Older age and a reduced likelihood of 2009 H1N1 virus infection. N. Engl. J. Med. 361, 2000\u20132001 (2009).","journal-title":"N. Engl. J. Med."},{"key":"2033_CR8","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1038\/s41591-022-01690-w","volume":"28","author":"M Auladell","year":"2022","unstructured":"Auladell, M. et al. Influenza virus infection history shapes antibody responses to influenza vaccination. Nat. Med. 28, 363\u2013372 (2022).","journal-title":"Nat. Med."},{"key":"2033_CR9","doi-asserted-by":"publisher","first-page":"e2004974","DOI":"10.1371\/journal.pbio.2004974","volume":"16","author":"AJ Kucharski","year":"2018","unstructured":"Kucharski, A. J., Lessler, J., Cummings, D. A. T. & Riley, S. Timescales of influenza A\/H3N2 antibody dynamics. PLoS Biol. 16, e2004974 (2018).","journal-title":"PLoS Biol."},{"key":"2033_CR10","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1126\/science.1090727","volume":"303","author":"BT Grenfell","year":"2004","unstructured":"Grenfell, B. T. et al. Unifying the epidemiological and evolutionary dynamics of pathogens. Science 303, 327\u2013332 (2004).","journal-title":"Science"},{"key":"2033_CR11","doi-asserted-by":"publisher","first-page":"E1701","DOI":"10.1073\/pnas.1525578113","volume":"113","author":"RA Neher","year":"2016","unstructured":"Neher, R. A., Bedford, T., Daniels, R. S., Russell, C. A. & Shraiman, B. I. Prediction, dynamics, and visualization of antigenic phenotypes of seasonal influenza viruses. Proc. Natl Acad. Sci. USA 113, E1701\u2013E1709 (2016).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2033_CR12","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.01914","volume":"3","author":"T Bedford","year":"2014","unstructured":"Bedford, T. et al. Integrating influenza antigenic dynamics with molecular evolution. Elife 3, e01914 (2014).","journal-title":"Elife"},{"key":"2033_CR13","doi-asserted-by":"publisher","first-page":"3881","DOI":"10.1016\/j.vaccine.2006.01.010","volume":"24","author":"V Gupta","year":"2006","unstructured":"Gupta, V., Earl, D. J. & Deem, M. W. Quantifying influenza vaccine efficacy and antigenic distance. Vaccine 24, 3881\u20133888 (2006).","journal-title":"Vaccine"},{"key":"2033_CR14","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1056\/NEJMoa066092","volume":"357","author":"IJ Amanna","year":"2007","unstructured":"Amanna, I. J., Carlson, N. E. & Slifka, M. K. Duration of humoral immunity to common viral and vaccine antigens. N. Engl. J. Med. 357, 1903\u20131915 (2007).","journal-title":"N. Engl. J. Med."},{"key":"2033_CR15","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1093\/infdis\/jiaa293","volume":"226","author":"LNM Hoa","year":"2022","unstructured":"Hoa, L. N. M. et al. Influenza A(H1N1)pdm09 but not A(H3N2) virus infection induces durable seroprotection: results from the Ha Nam cohort. J. Infect. Dis. 226, 59\u201369 (2022).","journal-title":"J. Infect. Dis."},{"key":"2033_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-28858-9","volume":"13","author":"S Wraith","year":"2022","unstructured":"Wraith, S. et al. Homotypic protection against influenza in a pediatric cohort in Managua, Nicaragua. Nat. Commun. 13, 1190 (2022).","journal-title":"Nat. Commun."},{"key":"2033_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-18465-x","volume":"11","author":"S Gouma","year":"2020","unstructured":"Gouma, S. et al. Middle-aged individuals may be in a perpetual state of H3N2 influenza virus susceptibility. Nat. Commun. 11, 4566 (2020).","journal-title":"Nat. Commun."},{"key":"2033_CR18","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1038\/s41591-019-0463-x","volume":"25","author":"S Ng","year":"2019","unstructured":"Ng, S. et al. Novel correlates of protection against pandemic H1N1 influenza A virus infection. Nat. Med. 25, 962\u2013967 (2019).","journal-title":"Nat. Med."},{"key":"2033_CR19","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1126\/science.1154137","volume":"320","author":"CA Russell","year":"2008","unstructured":"Russell, C. A. et al. The global circulation of seasonal influenza A (H3N2) viruses. Science 320, 340\u2013346 (2008).","journal-title":"Science"},{"key":"2033_CR20","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1126\/science.1097211","volume":"305","author":"DJ Smith","year":"2004","unstructured":"Smith, D. J. et al. Mapping the antigenic and genetic evolution of influenza virus. Science 305, 371\u2013376 (2004).","journal-title":"Science"},{"key":"2033_CR21","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1093\/infdis\/jiv367","volume":"213","author":"JM Fonville","year":"2016","unstructured":"Fonville, J. M. et al. Antigenic maps of influenza A(H3N2) produced with human antisera obtained after primary infection. J. Infect. Dis. 213, 31\u201338 (2016).","journal-title":"J. Infect. Dis."},{"key":"2033_CR22","doi-asserted-by":"publisher","first-page":"e1010317","DOI":"10.1371\/journal.ppat.1010317","volume":"18","author":"AF Brouwer","year":"2022","unstructured":"Brouwer, A. F. et al. Birth cohort relative to an influenza A virus\u2019s antigenic cluster introduction drives patterns of children\u2019s antibody titers. PLoS Pathog. 18, e1010317 (2022).","journal-title":"PLoS Pathog."},{"key":"2033_CR23","unstructured":"Worldwide Influenza Centre. Annual and Interim Reports (The Francis Crick Institute, 2003\u20132022)."},{"key":"2033_CR24","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1093\/infdis\/jiaa665","volume":"224","author":"M Hinojosa","year":"2021","unstructured":"Hinojosa, M. et al. Impact of immune priming, vaccination, and infection on influenza A(H3N2) antibody landscapes in children. J. Infect. Dis. 224, 469\u2013480 (2021).","journal-title":"J. Infect. Dis."},{"key":"2033_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-022-00490-0","volume":"7","author":"NU Ertesvag","year":"2022","unstructured":"Ertesvag, N. U. et al. Seasonal influenza vaccination expands hemagglutinin-specific antibody breadth to older and future A\/H3N2 viruses. npj Vaccines 7, 67 (2022).","journal-title":"npj Vaccines"},{"key":"2033_CR26","doi-asserted-by":"publisher","first-page":"e1002802","DOI":"10.1371\/journal.ppat.1002802","volume":"8","author":"J Lessler","year":"2012","unstructured":"Lessler, J. et al. Evidence for antigenic seniority in influenza A (H3N2) antibody responses in southern China. PLoS Pathog. 8, e1002802 (2012).","journal-title":"PLoS Pathog."},{"key":"2033_CR27","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1002\/gch2.1018","volume":"1","author":"S Elbe","year":"2017","unstructured":"Elbe, S. & Buckland-Merrett, G. Data, disease and diplomacy: GISAID\u2019s innovative contribution to global health. Glob. Chall. 1, 33\u201346 (2017).","journal-title":"Glob. Chall."},{"key":"2033_CR28","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1126\/science.1244730","volume":"342","author":"BF Koel","year":"2013","unstructured":"Koel, B. F. et al. Substitutions near the receptor binding site determine major antigenic change during influenza virus evolution. Science 342, 976\u2013979 (2013).","journal-title":"Science"},{"key":"2033_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-016-1738-1","volume":"16","author":"H Ushirogawa","year":"2016","unstructured":"Ushirogawa, H. et al. Re-emergence of H3N2 strains carrying potential neutralizing mutations at the N-linked glycosylation site at the hemagglutinin head, post the 2009 H1N1 pandemic. BMC Infect. Dis. 16, 380 (2016).","journal-title":"BMC Infect. Dis."},{"key":"2033_CR30","doi-asserted-by":"crossref","unstructured":"Perofsky, A. C. et al. Antigenic drift and subtype interference shape A(H3N2) epidemic dynamics in the United States. Elife 13, RP91849 (2024).","DOI":"10.7554\/eLife.91849.3"},{"key":"2033_CR31","doi-asserted-by":"publisher","first-page":"e1007989","DOI":"10.1371\/journal.pcbi.1007989","volume":"16","author":"W Yang","year":"2020","unstructured":"Yang, W., Lau, E. H. Y. & Cowling, B. J. Dynamic interactions of influenza viruses in Hong Kong during 1998\u20132018. PLoS Comput. Biol. 16, e1007989 (2020).","journal-title":"PLoS Comput. Biol."},{"key":"2033_CR32","doi-asserted-by":"publisher","first-page":"e1002082","DOI":"10.1371\/journal.pbio.1002082","volume":"13","author":"AJ Kucharski","year":"2015","unstructured":"Kucharski, A. J. et al. Estimating the life course of influenza A(H3N2) antibody responses from cross-sectional data. PLoS Biol. 13, e1002082 (2015).","journal-title":"PLoS Biol."},{"key":"2033_CR33","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1038\/nature06945","volume":"453","author":"A Rambaut","year":"2008","unstructured":"Rambaut, A. et al. The genomic and epidemiological dynamics of human influenza A virus. Nature 453, 615\u2013619 (2008).","journal-title":"Nature"},{"key":"2033_CR34","doi-asserted-by":"publisher","first-page":"2841","DOI":"10.1007\/s00216-021-03806-6","volume":"414","author":"Y Wang","year":"2022","unstructured":"Wang, Y., Tang, C. Y. & Wan, X. F. Antigenic characterization of influenza and SARS-CoV-2 viruses. Anal. Bioanal. Chem. 414, 2841\u20132881 (2022).","journal-title":"Anal. Bioanal. Chem."},{"key":"2033_CR35","first-page":"572","volume":"104","author":"T Francis","year":"1960","unstructured":"Francis, T. On the Doctrine of Original Antigenic Sin. Proc. Am. Philos. Soc. 104, 572\u2013578 (1960).","journal-title":"Proc. Am. Philos. Soc."},{"key":"2033_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.crmeth.2023.100540","volume":"3","author":"T Einav","year":"2023","unstructured":"Einav, T. & Ma, R. Using interpretable machine learning to extend heterogeneous antibody\u2013virus datasets. Cell Rep. Methods 3, 100540 (2023).","journal-title":"Cell Rep. Methods"},{"key":"2033_CR37","doi-asserted-by":"publisher","first-page":"446","DOI":"10.3389\/fimmu.2014.00446","volume":"5","author":"S Niewiesk","year":"2014","unstructured":"Niewiesk, S. Maternal antibodies: clinical significance, mechanism of interference with immune responses, and possible vaccination strategies. Front. Immunol. 5, 446 (2014).","journal-title":"Front. Immunol."},{"key":"2033_CR38","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abd3601","volume":"12","author":"HL Dugan","year":"2020","unstructured":"Dugan, H. L. et al. Preexisting immunity shapes distinct antibody landscapes after influenza virus infection and vaccination in humans. Sci. Transl. Med. 12, eabd3601 (2020).","journal-title":"Sci. Transl. Med."},{"key":"2033_CR39","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1038\/ni.3684","volume":"18","author":"R Nachbagauer","year":"2017","unstructured":"Nachbagauer, R. et al. Defining the antibody cross-reactome directed against the influenza virus surface glycoproteins. Nat. Immunol. 18, 464\u2013473 (2017).","journal-title":"Nat. Immunol."},{"key":"2033_CR40","unstructured":"Yang, B. Cross-reactivity breadth for influenza A viruses. GitHub https:\/\/github.com\/byyangyby\/influenza_A_cross-reactivity (2024)."}],"container-title":["Nature Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41564-025-02033-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41564-025-02033-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41564-025-02033-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T09:31:38Z","timestamp":1751448698000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41564-025-02033-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,10]]},"references-count":40,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2025,7]]}},"alternative-id":["2033"],"URL":"https:\/\/doi.org\/10.1038\/s41564-025-02033-4","relation":{},"ISSN":["2058-5276"],"issn-type":[{"value":"2058-5276","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,10]]},"assertion":[{"value":"16 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"B.J.C. consults for AstraZeneca, Fosun Pharma, GSK, Haleon, Moderna, Novavax, Roche, Sanofi Pasteur, and Pfizer. S.G.S. reports consulting for AstraZeneca, GSK, Moderna, Novavax, Pfizer, Sanofi, CSL Seqirus and Evo Health. S.S.W. has previously received a speaker\u2019s honorarium from Sanofi. D.A.T.C. reports research funding from Merck and Pfizer to his institution for research unrelated to this work. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}